Smith & Nephew
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Smith & Nephew sits in the top decile of US sponsors by registered trial count (#300 of 15,742 sponsors by registered trial count).
Smith & Nephew: 72 sponsored US clinical trials, 3 recruiting.
Smith & Nephew sponsors 72 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 39 completed. 4 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Total Knee Arthroplasty, with 3 trials.
Top-decile sponsor footprint
Smith & Nephew ranks in the top decile of sponsors by registered trial count (#300 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
39 of 59 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (66.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
72 total, page 2 of 2
TITAN™ Reverse Shoulder System
NCT02204228
Post-Market Evaluation of the Rotation Medical Rotator Cuff System
NCT02200939
A RCT to Compare the Effects of Two Wound Products on Biofilm Disruption in DFUs
NCT02181621
Mechanical vs. Radiofrequency-Based Debridement in the Treatment of Articular Cartilage Lesions
NCT01803880
Visionaire™ Versus Standard Instrumentation Safety and Efficacy in Total Knee Arthroplasty (TKA)
NCT01084772
PICO Breast Reduction Clinical Study Looking at Incision Healing Complications
NCT01640366
Safety and Efficacy of the Journey II BCS Total Knee System
NCT01705067
TRIGEN SURESHOT™ Distal Targeting System Study
NCT01327508
VISIONAIRE™ Value Study
NCT01107769
R3® Acetabular System in Patients With Degenerative Hip Disease
NCT01407029
LEGION™ Primary Safety and Efficacy
NCT04040985
Ascension PyroCarbon Radial Head Study
NCT02405234
Evaluation of the Use of EZCare/V1STA in the Management of Acute and Chronic Wounds
NCT00994162
Knee Articular Cartilage Debridement in Conjunction With Partial Meniscectomy
NCT00613535
INTUIT Hip Fracture Outcome Study
NCT00595634
Trial of Versajet Compared With Conventional Treatment in Acute and Chronic Wounds
NCT01050673
Ankle Joint Replacement Outcomes Study
NCT00503438
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
NCT00611585
A Study of Patients Treated With the Journey Deuce Bicompartmental Knee System
NCT01704326
Study Comparing VERSAJET With Conventional Surgical Procedures in the Removal of Unhealthy Tissue From Lower Limb Ulcers
NCT00521027
Safety and Effectiveness Study of the Reflection Ceramic Acetabular System
NCT00663351
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis
NCT02408471
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 4 |
Where Smith & Nephew enrollment is open (later-stage tilt)
3 recruiting of 72 indexed (4% open); 39 completed (54%).
Phase mix: 4 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Total Knee Arthroplasty (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Smith & Nephew: open-pipeline peers nationwide
Peers matched on 72 registered trials and 4% open enrollment, not the therapeutic-area sidebar.
Smith & Nephew sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 72 trials (± recruiting share)
- H. Lundbeck A/S · 72 trials · 7% recruiting
- University of California, Berkeley · 72 trials · 18% recruiting
- Denver Health and Hospital Authority · 73 trials · 5% recruiting
- Hugo W. Moser Research Institute at Kennedy Krieger · 73 trials · 23% recruiting
Sponsors near 4% open enrollment (± trial volume)
- Akebia Therapeutics · 4% recruiting · 24 trials
- Dentsply Sirona Implants and Consumables · 4% recruiting · 24 trials
- National Institute on Drug Abuse (NIDA) · 4% recruiting · 335 trials
- Medtronic - MITG · 4% recruiting · 119 trials
Related
What to do with this Smith & Nephew page
72 registered trials is a research-attention snapshot, not an endorsement of Smith & Nephew or any single study.
- 3 of Smith & Nephew's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Total Knee Arthroplasty is the condition Smith & Nephew studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Total Knee Arthroplasty trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Smith & Nephew pipeline card: 72 registered trials from official public datasets.Report a data error.